Premium
Urokinase‐type plasminogen activator and its receptor synergize to promote pathogenic proteolysis
Author(s) -
Zhou HongMing,
Nichols Anthony,
Meda Paolo,
Vassalli JeanDominique
Publication year - 2000
Publication title -
the embo journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.484
H-Index - 392
eISSN - 1460-2075
pISSN - 0261-4189
DOI - 10.1093/emboj/19.17.4817
Subject(s) - biology , proteolysis , plasminogen activator , urokinase , receptor , activator (genetics) , microbiology and biotechnology , cancer research , biochemistry , genetics , enzyme
Urokinase‐type plasminogen activator (uPA) is a potent catalyst of extracellular proteolysis, which also binds to a high‐affinity plasma membrane receptor (uPAR). Binding of uPA may influence pericellular proteolysis and/or activate intracellular signal transduction. Transgenic mice overexpressing either uPA or uPAR in basal epidermis and hair follicles had no detectable cutaneous alterations. In contrast, bi‐transgenic mice overexpressing both uPA and uPAR, obtained by crossing the two transgenic lines, developed extensive alopecia induced by involution of hair follicles, epidermal thickening and sub‐epidermal blisters. The phenotype was due to uPA catalytic activity since combined overexpression of uPAR and uPAR‐binding but catalytically inactive uPA in the same tissue was not detrimental in another bi‐transgenic line. It was accompanied by increased plasmin‐generating capacity, up‐regulation and activation of matrix metalloproteinases type‐2 and ‐9, and cleavage of uPAR. Thus, combined overexpression of uPA and uPAR acts in synergy to promote pathogenic extracellular proteolysis.